Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy

Area of Science:

• Immunology
• Allergy Research
• Nanotechnology in Medicine

Background:

• Allergen-specific immunotherapy (ASIT) offers long-lasting allergy relief but requires safety and efficiency improvements.
• Carbohydrate-based particles (CBPs) were previously proposed as novel adjuvants and allergen carriers for ASIT.
• This study aimed to assess the therapeutic potential of CBPs in ASIT using a cat allergy mouse model.

Purpose of the Study:

• To evaluate the efficacy of carbohydrate-based particles (CBPs) as an adjuvant and allergen carrier in allergen-specific immunotherapy (ASIT).
• To investigate the therapeutic potential of CBP-allergen conjugates in a mouse model of cat allergy.

Main Methods:

• BALB/c mice were sensitized with recombinant (r) Fel d 1 and challenged with cat dander extract (CDE).
• Therapeutic treatment involved rFel d 1 covalently coupled to CBPs (CBP-rFel d 1).
• Evaluated outcomes included airway hyper-reactivity (AHR), bronchoalveolar lavage (BAL) fluid analysis, serum immunoglobulin levels, and splenocyte responses.

Main Results:

• CBP-rFel d 1 treatment significantly reduced airway hyper-reactivity (AHR) and eosinophil infiltration in BAL fluid post-challenge.
• Serum levels of rFel d 1-specific IgE decreased, while IgG(2)a levels increased following CBP-rFel d 1 treatment.
• A trend towards decreased allergen-specific cellular response was observed.

Conclusions:

• Carbohydrate-based particles (CBPs) are effective as adjuvants and allergen carriers in ASIT.
• CBPs represent a promising strategy for enhancing the treatment of allergic diseases.